한글목차

급성 척수 손상 동향 및 전망

세계 급성 척수 손상 시장은 2024년부터 2030년까지 5.6%의 연평균 복합 성장률(CAGR)로 성장을 지속하여 2030년까지 약 96억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 조기 치료의 이점에 대한 인식 증가, 급성 척수 손상의 이환율 증가, 익스트림 스포츠 활동의 세계적인 인기 증가입니다. 세계 급성 척수 손상 시장의 미래는 병원 및 외상 센터 시장의 기회로 인해 유망합니다.

급성 척수 손상 시장 인사이트

Lucintel은 척수 손상 발병률 증가와 척수 손상 치료에 대한 인식이 높아짐에 따라 예측 기간 동안 불완전 척수 손상(ISCI)이 더 큰 부문을 차지할 것으로 예상하고 있습니다.

이 시장에서 병원은 입원 재활 프로그램이 증가하고 사람들을 지원하는 종합적인 서비스가 제공됨에 따라 병원이 계속해서 큰 비중을 차지할 것으로 예상됩니다.

북미는 고령화 인구의 급증, 잘 정비된 의료 시스템, 첨단 기술 도입 증가로 인해 가장 규모가 큰 지역이 될 것으로 예상됩니다.

시장 규모 및 추정치 : 급성 척수 손상 시장 규모를 금액(억 달러)으로 추정합니다.

동향 및 예측 분석 : 각 부문별, 지역별 시장 동향(2018-2023년) 및 예측(2024-2030년)을 분석합니다.

부문별 분석 : 유형별, 최종사용자별, 지역별 급성 척수 손상 시장 규모를 금액($B)으로 추정합니다.

지역별 분석 : 북미, 유럽, 아시아태평양 및 기타 세계 급성 척수 손상 시장 분석.

전략적 분석 : 급성 척수 손상 시장 유형별, 최종 용도별, 지역별 성장 기회 분석.

전략적 분석 : 급성 척수 손상 시장 M&A, 신제품 개발, 경쟁 구도 등.

Porter's Five Forces 모델을 기반으로 한 산업 경쟁 강도 분석.

이 보고서는 다음과 같은 11가지 주요 질문에 대한 답변을 담고 있습니다.

• Q.1. 시장 부문 중 가장 유망하고 성장성이 높은 기회는 무엇인가?
• Q.2. 어떤 부문이 더 빠른 속도로 성장할 것이며, 그 이유는 무엇인가?
• Q.3. 향후 성장이 가속화될 것으로 예상되는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은? 시장의 주요 과제와 비즈니스 리스크는 무엇인가?
• Q.5. 이 시장에서의 비즈니스 리스크와 경쟁 위협은 무엇인가?
• Q.6. 이 시장의 새로운 트렌드와 그 이유는?
• Q.7. 시장에서의 고객 수요 변화에는 어떤 것들이 있는가?
• Q.8. 이 시장의 새로운 발전과 그 발전을 주도하고 있는 기업은?
• Q.9. 이 시장의 주요 기업은? 주요 기업들은 사업 성장을 위해 어떤 전략적 노력을 기울이고 있는가?
• Q.10. 이 시장의 경쟁 제품에는 어떤 것들이 있으며, 소재 및 제품 대체에 따른 시장 점유율 하락의 위협은 어느 정도인가?
• Q.11. 지난 5년간 어떤 M&A가 이루어졌고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 급성 척수 손상 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향 및 예측 분석(2018-2030년)

• 거시경제 동향(2018년-2023년)과 예측(2024년-2030년)
• 세계의 급성 척수 손상 시장 동향(2018년-2023년)과 예측(2024년-2030년)
• 유형별 세계의 급성 척수 손상 시장
  • 완전 척수 손상
  • 불완전 척수 손상
• 최종 용도별 세계의 급성 척수 손상 시장
  • 병원
  • 외상 센터

제4장 지역별 시장 동향 및 예측 분석(2018-2030년)

• 지역별 세계의 급성 척수 손상 시장
• 북미의 급성 척수 손상 시장
• 유럽의 급성 척수 손상 시장
• 아시아태평양의 급성 척수 손상 시장
• 기타 지역의 급성 척수 손상 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 유형별 세계의 급성 척수 손상 시장 성장 기회
  • 최종 용도별 세계의 급성 척수 손상 시장 성장 기회
  • 지역별 세계의 급성 척수 손상 시장 성장 기회
• 세계 급성 척수 손상 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 급성 척수 손상 시장 능력 확대
  • 세계 급성 척수 손상 시장의 인수합병(M&A) 및 합작투자(JV)
  • 인증 및 라이선싱

제7장 유력 기업의 기업 개요

• Novartis
• Tenax Therapeutics
• Accure Pharma
• Acorda Therapeutics
• Asterias Biotherapeutics
• ReNetX Bio
• BioArctic
• BioTime
• InVivo Therapeutics
• Kringle Pharma

영문목차

Acute Spinal Cord Injury Trends and Forecast

The future of the global acute spinal cord injury market looks promising with opportunities in the hospital and trauma center markets. The global acute spinal cord injury market is expected to reach an estimated $9.6 billion by 2030 with a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are growing awareness towards the benefits of early treatment, rising incidence of acute spinal cord injury, and growing popularity of extreme sports activities across the globe.

A more than 150-page report is developed to help in your business decisions.

Acute Spinal Cord Injury by Segment

The study includes a forecast for the global acute spinal cord injury by type, end use, and region.

Acute Spinal Cord Injury Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Complete Spinal Cord Injury
• Incomplete Spinal Cord Injury

Acute Spinal Cord Injury Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Trauma Centers

Acute Spinal Cord Injury Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Acute Spinal Cord Injury Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies acute spinal cord injury companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the acute spinal cord injury companies profiled in this report include-

• Novartis
• Tenax Therapeutics
• Accure Pharma
• Acorda Therapeutics
• Asterias Biotherapeutics
• Renetx Bio
• Bioarctic
• Biotime
• Invivo Therapeutics
• Kringle Pharma

Acute Spinal Cord Injury Market Insights

Lucintel forecasts that incomplete spinal cord injury (ISCI) will remain the larger segment over the forecast period due to increasing incidence of spinal cord injuries and growing awareness towards treatment of spinal cord injuries.

Within this market, hospital is expected to remain the larger segment due to growing number of inpatient rehabilitation programs at hospitals to deliver comprehensive services to help people.

North America will remain the largest region due to surge in aging population, well-developed healthcare system, and increasing adoption of advanced technologies in the region.

Features of the Global Acute Spinal Cord Injury Market

Market Size Estimates: Acute spinal cord injury market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Acute spinal cord injury market size by type, end use, and region in terms of value ($B).

Regional Analysis: Acute spinal cord injury market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the acute spinal cord injury market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the acute spinal cord injury market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the acute spinal cord injury market size?

Answer: The global acute spinal cord injury market is expected to reach an estimated $9.6 billion by 2030.

Q.2 What is the growth forecast for acute spinal cord injury market?

Answer: The global acute spinal cord injury market is expected to grow with a CAGR of 5.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the acute spinal cord injury market?

Answer: The major drivers for this market are growing awareness towards the benefits of early treatment, rising incidence of acute spinal cord injury, and growing popularity of extreme sports activities across the globe.

Q4. What are the major segments for acute spinal cord injury market?

Answer: The future of the acute spinal cord injury market looks promising with opportunities in the hospital and trauma center markets.

Q5. Who are the key acute spinal cord injury market companies?

Answer: Some of the key acute spinal cord injury companies are as follows:

• Novartis
• Tenax Therapeutics
• Accure Pharma
• Acorda Therapeutics
• Asterias Biotherapeutics
• Renetx Bio
• Bioarctic
• Biotime
• Invivo Therapeutics
• Kringle Pharma

Q6. Which acute spinal cord injury market segment will be the largest in future?

Answer: Lucintel forecasts that incomplete spinal cord injury (ISCI) will remain the larger segment over the forecast period due to increasing incidence of spinal cord injuries and growing awareness towards treatment of spinal cord injuries.

Q7. In acute spinal cord injury market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to surge in aging population, well-developed healthcare system, and increasing adoption of advanced technologies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the acute spinal cord injury market by type (complete spinal cord injury and incomplete spinal cord injury), end use (hospitals and trauma centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Acute Spinal Cord Injury Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Acute Spinal Cord Injury Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Acute Spinal Cord Injury Market by Type
  • 3.3.1: Complete Spinal Cord Injury
  • 3.3.2: Incomplete Spinal Cord Injury
• 3.4: Global Acute Spinal Cord Injury Market by End Use
  • 3.4.1: Hospitals
  • 3.4.2: Trauma Centers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Acute Spinal Cord Injury Market by Region
• 4.2: North American Acute Spinal Cord Injury Market
  • 4.2.2: North American Acute Spinal Cord Injury Market by End Use: Hospitals and Trauma Centers
• 4.3: European Acute Spinal Cord Injury Market
  • 4.3.1: European Acute Spinal Cord Injury Market by Type: Complete Spinal Cord Injury and Incomplete Spinal Cord Injury
  • 4.3.2: European Acute Spinal Cord Injury Market by End Use: Hospitals and Trauma Centers
• 4.4: APAC Acute Spinal Cord Injury Market
  • 4.4.1: APAC Acute Spinal Cord Injury Market by Type: Complete Spinal Cord Injury and Incomplete Spinal Cord Injury
  • 4.4.2: APAC Acute Spinal Cord Injury Market by End Use: Hospitals and Trauma Centers
• 4.5: ROW Acute Spinal Cord Injury Market
  • 4.5.1: ROW Acute Spinal Cord Injury Market by Type: Complete Spinal Cord Injury and Incomplete Spinal Cord Injury
  • 4.5.2: ROW Acute Spinal Cord Injury Market by End Use: Hospitals and Trauma Centers

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Acute Spinal Cord Injury Market by Type
  • 6.1.2: Growth Opportunities for the Global Acute Spinal Cord Injury Market by End Use
  • 6.1.3: Growth Opportunities for the Global Acute Spinal Cord Injury Market by Region
• 6.2: Emerging Trends in the Global Acute Spinal Cord Injury Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Acute Spinal Cord Injury Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Acute Spinal Cord Injury Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Novartis
• 7.2: Tenax Therapeutics
• 7.3: Accure Pharma
• 7.4: Acorda Therapeutics
• 7.5: Asterias Biotherapeutics
• 7.6: ReNetX Bio
• 7.7: BioArctic
• 7.8: BioTime
• 7.9: InVivo Therapeutics
• 7.10: Kringle Pharma